Latest filing published 14 May 2020 for 10x Genomics, Inc., €59.2M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +115.6%Entry US$56.78 · Close at T+365 US$122.39
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Foresite Capital Management I, LLC: trading record in brief
Filings by Foresite Capital Management I, LLC span 2 companies, the busiest being 10x Genomics, Inc. and Ambit Biosciences Corp. Between 17 May 2013 and 13 May 2020, the trades on record add up to 36 filings.
The open-market side counts 9 purchases for €7.0M alongside 4 sales for €147.0M. Netting one side against the other leaves €139.9M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2020 to date brings no purchases and 4 sales.
Half of the purchases are above €42k and half below.
The latest filing, published on 14 May 2020, reports a transaction in 10x Genomics, Inc. The latest purchase dates back some time: it was published 2,610 days ago, on 16 September 2019. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Foresite Capital Management I, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 800,000 shares@ US$80.1340.3% of flowClass A Common StockSEC:0000899243-20-013113:1
- 650,000 shares@ US$80.1332.7% of flowClass A Common StockSEC:0000899243-20-013113:2
- 1,930,198 sharesClass A Common StockSEC:0000899243-20-013113:0
- 500,000 sharesClass A Common StockSEC:0000899243-20-012367:0
- 1,500,000 sharesClass A Common StockSEC:0000899243-20-012367:1
- 700,000 sharesClass A Common StockSEC:0000899243-20-011300:0
- 178,584 sharesClass A Common StockSEC:0000899243-20-011300:1
- 178,584 sharesClass A Common StockSEC:0000899243-20-011300:2
- 92,258 sharesClass A Common StockSEC:0000899243-20-011300:3
- 1,000,000 sharesClass A Common StockSEC:0000899243-20-011300:4
- 788,317 sharesClass A Common StockSEC:0000899243-20-010769:0
- 433,725 sharesClass A Common StockSEC:0000899243-20-010769:1
- 201,115 sharesClass A Common StockSEC:0000899243-20-010769:2
- 201,115 sharesClass A Common StockSEC:0000899243-20-010769:3
- 21,686 sharesClass A Common StockSEC:0000899243-20-010769:4
- 21,686 sharesClass A Common StockSEC:0000899243-20-010769:5
- 109,849 sharesClass A Common StockSEC:0000899243-20-010769:6
- 1,500,000 sharesClass A Common StockSEC:0000899243-20-010769:7
- 2,170,619 sharesClass A Common StockSEC:0000899243-20-009578:0
- 500,000 shares@ US$59.0018.0% of flowClass A Common StockSEC:0000899243-20-009021:2
- 250,000 shares@ US$59.009.0% of flowClass A Common StockSEC:0000899243-20-009021:3
- 1,447,079 sharesClass A Common StockSEC:0000899243-20-009021:0
- 683,725 sharesClass A Common StockSEC:0000899243-20-009021:1
- 947,079 sharesClass A Common StockSEC:0000899243-20-009021:4
- 241,619 sharesClass A Common StockSEC:0000899243-20-009021:5
25 of 36 declarations
